Aminohippurate Sodium, also known as sodium para-aminohippurate or PAH, is a diagnostic agent used in medical imaging to assess renal blood flow and function. This drug is administered intravenously and works by being filtered by the kidneys and then excreted into the urine. By measuring the rate at which Aminohippurate Sodium is cleared from the blood, healthcare providers can determine the renal plasma flow and glomerular filtration rate, which are important indicators of kidney function.
Aminohippurate Sodium is a safe and well-tolerated drug, with minimal side effects reported. Some patients may experience mild discomfort at the injection site or a temporary metallic taste in the mouth, but these symptoms typically resolve quickly. It is important to inform your healthcare provider of any allergies or medical conditions you may have before receiving Aminohippurate Sodium to ensure its safety and effectiveness.
As a medical professional, I recommend Aminohippurate Sodium for patients undergoing renal function testing or those with suspected kidney disease. This drug provides valuable information about kidney function and can help guide treatment decisions for patients with renal impairment. If you have any questions or concerns about Aminohippurate Sodium or its use in your medical care, please do not hesitate to discuss them with your healthcare provider.
In conclusion, Aminohippurate Sodium is a valuable diagnostic tool in assessing renal function and blood flow. Its safety profile and effectiveness make it a reliable option for patients undergoing kidney function testing. Trust in your healthcare provider to guide you through the process and provide you with the best possible care.
EN 
ES 
FR 
PT 
ZH